1. P3–305: An overview of the medical food Souvenaid clinical trial program. (1st July 2013) Authors: Wieggers, R.L.; Kamphuis, P.; Stam, Cornelis; Shah, Raj; Bennett, David; Hartmann, T.; Soininen, Hilkka; Marcel, Olde Rikkert; Scheltens, Philip Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 17 Page Start: P669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P3–306: A randomized controlled trial investigating the effects of Souvenaid in prodromal Alzheimer's disease: Baseline characteristics of the LipiDiDiet study. (1st July 2013) Authors: Visser, Pieter Jelle; Soininen, Hilkka; Kivipelto, Miia; Freund‐Levi, Y.; Kamphuis, P.; Wieggers, R.L.; Hartmann, T. Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 17 Page Start: P669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P4–265: Mechanism of action of the specific nutrient combination Fortasyn® Connect, which is designed to enhance synapse formation and function in Alzheimer's disease. (1st July 2013) Authors: Wieggers, R.L.; van Wijk, Nick; de Wilde, Martijn; Hageman, Robert; Groenendijk, Martine; Kamphuis, Patrick; Broersen, Laus; Sijben, John Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 20 Page Start: P802 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗